BiotechTube
Home/Brimstalt Therapeutics/Dev Chatterjee
DC

Dev Chatterjee

Team Member (MD, PhD)

Brimstalt Therapeutics

Therapeutic Areas

Oncology

Brimstalt Therapeutics Pipeline

DrugIndicationPhase
Lead Prodrug CandidateTAE-expressing cancers (initial focus: Renal Cell Carcinoma, Prostate Cancer)Preclinical

Leadership Team at Brimstalt Therapeutics

RH
Ross Hamilton
Team Member (PhD)
LC
Leniher Castan
Team Member (PhD)
SV
Stephanie Vega
Team Member (PhD)
View full Brimstalt Therapeutics profile